Aetna 2027 Star Ratings Reflect Strong Clinical Quality and Member Experience

Aetna secures top CMS ratings for 2027 Medicare Advantage plans, covering most members.

What the company is saying

Aetna, part of CVS Health (NYSE:CVS), highlights that over 69% of its Medicare Advantage members are enrolled in 2027 plans rated 4 stars or higher by CMS. The company frames this as evidence of leadership in the Star Ratings program for the third consecutive year, emphasizing clinical quality, preventive care, and member experience. Steve Nelson, President of Aetna, attributes these results to disciplined execution and a focus on fundamentals, expressing confidence in returning to appropriate margins and improving member outcomes. The announcement details high scores across multiple CMS measures, including a 4.77 for Plan All-Cause Readmissions and a perfect 5.00 for Care for Older Adults Medication Review. The tone is assertive, positioning Aetna as a market leader and underscoring operational excellence, but does not provide comparative or historical data to substantiate relative performance claims.

What the data suggests

The disclosed data shows that more than 69% of Aetna’s Medicare Advantage members are in plans rated 4 stars or higher for 2027. Key CMS Star Ratings include 4.77 for Plan All-Cause Readmissions, 5.00 for Care for Older Adults Medication Review, 4.19 for Colorectal Cancer Screening, and 4.07 for Breast Cancer Screening. Member experience metrics are also strong, with scores such as 4.29 for Complaints about the Drug Plan, 4.04 for Customer Service, and 4.22 for Rating of Health Care Quality. Operational measures include a 4.99 for Call Center Foreign Language Interpreter and Teletypewriter Availability and 4.01 for Drug Price Accuracy. CVS Health’s scale is reinforced by approximately 9,000 retail pharmacy locations, over 1,000 clinics, 87 million plan members, and 37 million people served through insurance products as of June 30, 2026. The announcement does not provide historical or peer comparison data, nor any financial performance figures, so the direct impact on profitability or growth trends cannot be assessed from this release alone.

Analysis

The announcement is generally positive in tone and is supported by detailed, realised CMS Star Ratings for 2027, as well as current operational scale metrics (locations, clinics, membership). The majority of claims are factual and relate to already-published Star Ratings, with only one forward-looking statement about returning to appropriate margins and improving member outcomes. However, the release lacks any financial or profitability metrics (revenue, net income, EBITDA, margins), which limits the ability to assess whether operational quality is translating into shareholder value. The claim of being a top performer for the 'third consecutive year' is not substantiated with comparative or historical data. The language around 'operational excellence' and 'strong performance' is somewhat promotional, but the underlying data is specific and realised. There is no evidence of a large new capital outlay or long-dated, uncertain returns.

Risk flags

• ●The absence of comparative or historical data makes it difficult to verify claims of being a top performer for three consecutive years or to benchmark Aetna’s performance against peers. This limits transparency and may obscure underlying trends.
• ●No financial metrics such as revenue, margin, or net income are disclosed, so investors cannot determine whether high operational and quality scores are translating into improved profitability or shareholder returns.
• ●The announcement relies heavily on CMS Star Ratings, which, while important, are only one component of overall business performance. Changes in CMS methodology, competitive responses, or shifts in member demographics could impact future ratings and enrollment.

Bottom line

Aetna’s 2027 Medicare Advantage plans have achieved high CMS Star Ratings, with more than 69% of members in 4-star or better plans, and strong scores across clinical, preventive, and operational measures. CVS Health’s scale remains significant, with 9,000 pharmacies, over 1,000 clinics, 87 million plan members, and 37 million insurance customers as of June 30, 2026. While these operational metrics are positive and position Aetna well for the upcoming Medicare Annual Enrollment Period, the lack of financial data or historical context means investors cannot gauge the impact on margins or growth. The company’s narrative is credible on operational quality but unsubstantiated regarding multi-year leadership or financial trajectory. Investors should focus on forthcoming enrollment and financial updates to assess whether these quality gains drive improved profitability. The most important takeaway is that Aetna’s operational execution is strong, but the financial implications remain unclear.

Announcement summary

(NYSE:CVS) Aetna, a CVS Health company, announced that more than 69 percent of its Medicare Advantage (MA) members are in 2027 plans rated 4 stars or higher (out of 5 stars) by the Centers for Medicare & Medicaid Services (CMS). This marks the third consecutive year that Aetna is positioned as one of the highest-performing large, publicly traded Medicare Advantage organizations in the CMS Star Ratings program. Steve Nelson, President of Aetna, stated that the company’s focus on fundamentals and disciplined execution has contributed to strong performance in clinical quality and operational excellence. In the 2027 Star Ratings, Aetna achieved a score of 4.77 out of 5 stars on Plan All-Cause Readmissions, reflecting the effectiveness of its care coordination programs and provider partnerships. The company received a score of 5.00 on Care for Older Adults Medication Review and 4.03 on Care for Older Adults Functional Status Assessment. Preventive screening measures were also strong, with scores of 4.19 for Colorectal Cancer Screening and 4.07 for Breast Cancer Screening. Member experience and customer support measures included a score of 4.29 for Complaints about the Drug Plan, 4.04 for Customer Service, 3.89 for Getting Needed Care, and 4.07 for Getting Needed Prescription Drugs. Aetna earned a 4.22 on Rating of Health Care Quality. Operational excellence was demonstrated with scores of 4.99 for Call Center Foreign Language Interpreter and Teletypewriter Availability, 4.08 for Reviewing Appeals Decisions, 4.01 for Plan Makes Timely Decisions About Appeals, and 4.01 for Drug Price Accuracy. As of June 30, 2026, CVS Health had approximately 9,000 retail pharmacy locations and more than 1,000 walk-in and primary care medical clinics. CVS Health is a leading pharmacy benefits manager with approximately 87 million plan members and serves an estimated 37 million people through a broad range of health insurance products and related services. The Medicare Annual Enrollment Period runs from October 15 through December 7, 2026. The information in this release is based on 2027 Star Ratings data published by CMS on October 8, 2026, and MA and MAPD enrollment as of September 2026.

Disagree with this article?